DelveInsight’s “Acute ischemic stroke (AIS) Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Acute ischemic stroke (AIS), historical and forecasted epidemiology as well as the Acute ischemic stroke (AIS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Acute ischemic stroke (AIS) market report provides current treatment practices, emerging drugs, Acute ischemic stroke (AIS) market share of the individual therapies, current and forecasted Acute ischemic stroke (AIS) market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Acute ischemic stroke (AIS) treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute ischemic stroke (AIS) market
Some of the key facts of the Acute ischemic stroke (AIS) Market Report:
- As per the study conducted by Andrej Netland Khanevski et. al. 2019, the cumulative incidence of clinical recurrent IS was found to be 5.4% at 1 year and 11.3% at 5 years.
- As per the study conducted by Amy Guzik et. al. titled “Stroke Epidemiology and Risk Factor Management”, 2017, approximately 85% of strokes are ischemic. While ischemic strokes are more common in men than women when young and middle-aged, women have a higher lifetime risk of stroke than men (20% to 21% versus 14% to 17%) with poorer functional outcomes.
Key benefits of the Acute Ischemic Stroke Market report:
- The report covers the descriptive overview of Acute ischemic stroke (AIS), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Acute ischemic stroke (AIS) epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Acute ischemic stroke (AIS) is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of the Acute ischemic stroke (AIS) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Acute ischemic stroke (AIS) market
Got queries? Click here to know more about the Acute Ischemic Stroke Landscape
Acute Ischemic Stroke Overview
Acute Ischemic Stroke (AIS) occurs when blood flow through a brain artery is blocked by a clot- a mass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop within the body. A thrombotic stroke, the more common of the two, occurs when a clot forms within an artery in the brain. An embolic stroke occurs when a clot or small piece of plaque (fatty deposit) breaks off from elsewhere in the body, such as the heart, and travels through the bloodstream only to become stuck in a narrower vessel in the brain. Symptoms of stroke depend on the severity and location of the stroke in the brain. Some people do not experience any symptoms while others experience may experience only one. Most people, however, experience a combination of symptoms. Symptoms may include paralysis on one side of the body, dizziness or loss of balance, problems with eyesight, etc.
Acute Ischemic Stroke Epidemiological Insight:
- As per the study conducted by Edward C Jauch et. al. 2019, nearly 800,000 people suffer from strokes each year in the United States and 82–92% of these strokes are ischemic. Stroke is the fifth leading cause of adult death and disability.
- According to the World Health Organization (WHO), an estimated 15 million individuals worldwide suffer from stroke each year. Of these, 5 million die, and another 5 million are left permanently disabled.
- Although stroke is often considered a disease in elderly individuals, one-third of strokes occur in individuals younger than 65 years. The risk of stroke increases with age, especially in patients older than 64 years [Edward C Jauch et. al. 2019].
- According to the study conducted by Edward C Jauch et. al. 2019, men are at higher risk for Acute Ischemic Stroke than women.
Acute Ischemic Stroke Market Epidemiological Segmentation
- Acute Ischemic Stroke (AIS) is total prevalent cases
- Acute Ischemic Stroke (AIS) gender-specific cases
- Acute Ischemic Stroke (AIS) diagnosis and specific cases
- Acute Ischemic Stroke (AIS) age-specific prevalent cases
Acute Ischemic Stroke Market Outlook
The Acute ischemic stroke (AIS) market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Acute ischemic stroke (AIS) market trends by analyzing the impact of current Acute ischemic stroke (AIS) therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Acute ischemic stroke (AIS) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Acute ischemic stroke (AIS) market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Acute ischemic stroke (AIS) market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @Acute Ischemic Stroke Market Landscape
Acute Ischemic Stroke Key Companies
- Bristol-Myers Squibb
- Lumosa Therapeutics
- AbbVie
- and many more
Acute Ischemic Stroke Therapies
- Athersys/Healios
- BMS-986177
- Elezanumab
- and many more
Table of Contents
- Key Insights
- Report Introduction
- Executive Summary of Acute Ischemic Stroke
- Disease Background and Overview
- Epidemiology and patient population
- The United States
- EU 5
- Acute Ischemic Stroke Emerging Therapies
- Acute Ischemic Stroke Market Outlook
- Market Access and Reimbursement of Therapies
- Appendix
- Acute Ischemic Stroke Report Methodology
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
Click here to read more about Acute Ischemic Stroke Market
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/